Cannara Biotech (OTCMKTS:CNBTF) Trading Up 0.3% – Should You Buy?

Cannara Biotech (OTCMKTS:CNBTFGet Free Report) shares were up 0.3% during mid-day trading on Monday . The company traded as high as $1.30 and last traded at $1.30. Approximately 3,078 shares traded hands during mid-day trading, a decline of 91% from the average daily volume of 33,127 shares. The stock had previously closed at $1.2959.

Cannara Biotech Trading Up 0.5%

The company has a 50-day moving average of $1.33 and a 200 day moving average of $1.28.

Cannara Biotech Holdings Inc (OTCMKTS:CNBTF) is a biotechnology and natural health company focused on the development, production and distribution of plant-derived formulations, including cannabinoid-based products. Headquartered in Canada, the company integrates research and development with large-scale extraction and formulation processes to serve the pharmaceutical, cosmetic and wellness industries.

The company’s offerings comprise high-purity botanical extracts, nutraceutical ingredients and cosmetic actives developed using proprietary extraction and purification techniques.

Featured Stories

Receive News & Ratings for Cannara Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannara Biotech and related companies with MarketBeat.com's FREE daily email newsletter.